COMPLETED

Co-Use of Opioid Medications and Alcohol Prevention Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication misuse; test its acceptability, feasibility, and preliminary efficacy; and identify barriers and facilitators to large-scale research and system-level implementation. Results of this study will directly inform a fully-powered subsequent multisite trial.

Official Title

Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)

Quick Facts

Study Start:2023-05-01
Study Completion:2024-08-19
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05599672

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English speaking
  2. * ≥18 years
  3. * Not receiving cancer treatment
  4. * Current alcohol use
  5. * Prescribed an opioid medication
  1. * SA 2 exclusion
  2. * Are pregnant
  3. * Cannot provide collateral contact information for ≥2 persons
  4. * Do not have a reliable land line or mobile phone to be contacted by study staff
  5. * Are filling only buprenorphine
  6. * Plan to leave the area for an extended period of time in the next 3-months, or
  7. * Have experienced a psychotic and/or manic episode in the last 30 days

Contacts and Locations

Study Locations (Sites)

University of Tennessee College of Medicine
Nashville, Tennessee, 38103
United States

Collaborators and Investigators

Sponsor: University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-01
Study Completion Date2024-08-19

Study Record Updates

Study Start Date2023-05-01
Study Completion Date2024-08-19

Terms related to this study

Additional Relevant MeSH Terms

  • Alcohol Drinking
  • Opioid Use